Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study.
Odawara M, Kadowaki T, Naito Y. Odawara M, et al. J Diabetes Complications. 2015 Jan-Feb;29(1):127-33. doi: 10.1016/j.jdiacomp.2014.09.012. Epub 2014 Sep 28. J Diabetes Complications. 2015. PMID: 25449981 Free article.
Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.
Sone H, Tanaka S, Tanaka S, Iimuro S, Ishibashi S, Oikawa S, Shimano H, Katayama S, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study Group. Sone H, et al. Diabetes Care. 2012 May;35(5):1150-7. doi: 10.2337/dc11-1412. Epub 2012 Feb 14. Diabetes Care. 2012. PMID: 22338107 Free PMC article.
Safety and efficacy of addition of sitagliptin to rapid-acting insulin secretagogues for glycemic control, including post-prandial hyperglycemia, among Japanese with type 2 diabetes mellitus.
Tajima N, Kadowaki T, Odawara M, Minamide T, Seki A, Oki K, Nagayasu R, Ferreira JCA. Tajima N, et al. Among authors: odawara m. Diabetol Int. 2015 Aug 28;7(2):155-166. doi: 10.1007/s13340-015-0230-2. eCollection 2016 Jun. Diabetol Int. 2015. PMID: 30603259 Free PMC article.
Predictors for achieving target glycemic control in Japanese patients with type 2 diabetes after initiation of basal supported oral therapy using insulin glargine: sub-analysis of the ALOHA2 study, drug use surveillance in Japan.
Ikeda Y, Tsukube S, Kadowaki T, Odawara M. Ikeda Y, et al. Among authors: odawara m. Diabetol Int. 2015 Oct 5;7(2):188-198. doi: 10.1007/s13340-015-0236-9. eCollection 2016 Jun. Diabetol Int. 2015. PMID: 30603263 Free PMC article.
Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study, drug-use surveillance in Japan.
Tsukube S, Kadowaki T, Odawara M. Tsukube S, et al. Among authors: odawara m. Diabetol Int. 2016 Jan 14;7(3):299-307. doi: 10.1007/s13340-015-0250-y. eCollection 2016 Sep. Diabetol Int. 2016. PMID: 30603277 Free PMC article.
214 results